Medical oncologists William Tap and Ping Chi describe an investigational combination therapy for untreated advanced gastrointestinal stromal tumors.
Over the past two decades, Memorial Sloan Kettering’s multidisciplinary team of experts has surgically treated more than 8,000 individuals with soft tissue sarcomas – one of the rarest of cancers – and has provided consultations to almost twice that number. The Soft Tissue Sarcoma Disease Management Team includes specialists in surgery, medical oncology, radiation oncology, diagnostic radiology, nursing, pathology, biostatistics, immunology, epidemiology, and psychiatry.
In pioneering advances in limb-sparing operations that combine radiation therapy and/or chemotherapy, we offer a high rate of tumor control without the need for amputation in many cases. Our physicians and researchers in the laboratory are simultaneously investigating new types of adjuvant treatments for this cancer, including novel chemotherapy agents designed to inhibit tumorigenesis by targeting the tumor cell cycle.